Factores determinantes en el éxito de un tratamiento antitabaco

Smoking cessation programs have an efficacy of approximately 30%. Different factors related to the patients may influence this figure. Aim To identify determinant factors for smoking cessation after one year of treatment and to determine if bupropion and nicotine substitutes are effective in smoking...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tamblay,Natalia, Seijas,Daniel
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2008
Materias:	Bupropion Nicotine Smoking
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008000200006
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872008000200006
record_format	dspace
spelling	oai:scielo:S0034-988720080002000062008-07-28Factores determinantes en el éxito de un tratamiento antitabacoTamblay,NataliaSeijas,Daniel Bupropion Nicotine Smoking Smoking cessation programs have an efficacy of approximately 30%. Different factors related to the patients may influence this figure. Aim To identify determinant factors for smoking cessation after one year of treatment and to determine if bupropion and nicotine substitutes are effective in smoking cessation treatments. Material and methods: Follow up of 68 patients that attended a smokers clinic at a General Hospital. The patients filled up a questionnaire which included demographic, morbid and smoking habits data. They were subjected to a psychiatric interview to determine their treatment. One year later, patients were contacted by telephone and were asked if they remained without smoking. Results: After one year, 41% of patients responded that they were abstinent. On univariate analysis, male gender appeared as a protective factor associated to abstinence. On multivariate analysis, the use of bupropion appeared as a protective factor. A high score on the automatic item of the smoking motivation questionnaire appeared as a risk factor. The presence of respiratory diseases and the male gender were borderline significant protective factors. Nicotine substitutes were not associated with better abstinence rates. Conclusions: In this sample of smokers, the use of bupropion was associated with better abstinence rates and a high motivation to smoke appeared as a risk factor to continue smokinginfo:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.136 n.2 20082008-02-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008000200006es10.4067/S0034-98872008000200006
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Bupropion Nicotine Smoking
spellingShingle	Bupropion Nicotine Smoking Tamblay,Natalia Seijas,Daniel Factores determinantes en el éxito de un tratamiento antitabaco
description	Smoking cessation programs have an efficacy of approximately 30%. Different factors related to the patients may influence this figure. Aim To identify determinant factors for smoking cessation after one year of treatment and to determine if bupropion and nicotine substitutes are effective in smoking cessation treatments. Material and methods: Follow up of 68 patients that attended a smokers clinic at a General Hospital. The patients filled up a questionnaire which included demographic, morbid and smoking habits data. They were subjected to a psychiatric interview to determine their treatment. One year later, patients were contacted by telephone and were asked if they remained without smoking. Results: After one year, 41% of patients responded that they were abstinent. On univariate analysis, male gender appeared as a protective factor associated to abstinence. On multivariate analysis, the use of bupropion appeared as a protective factor. A high score on the automatic item of the smoking motivation questionnaire appeared as a risk factor. The presence of respiratory diseases and the male gender were borderline significant protective factors. Nicotine substitutes were not associated with better abstinence rates. Conclusions: In this sample of smokers, the use of bupropion was associated with better abstinence rates and a high motivation to smoke appeared as a risk factor to continue smoking
author	Tamblay,Natalia Seijas,Daniel
author_facet	Tamblay,Natalia Seijas,Daniel
author_sort	Tamblay,Natalia
title	Factores determinantes en el éxito de un tratamiento antitabaco
title_short	Factores determinantes en el éxito de un tratamiento antitabaco
title_full	Factores determinantes en el éxito de un tratamiento antitabaco
title_fullStr	Factores determinantes en el éxito de un tratamiento antitabaco
title_full_unstemmed	Factores determinantes en el éxito de un tratamiento antitabaco
title_sort	factores determinantes en el éxito de un tratamiento antitabaco
publisher	Sociedad Médica de Santiago
publishDate	2008
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008000200006
work_keys_str_mv	AT tamblaynatalia factoresdeterminantesenelexitodeuntratamientoantitabaco AT seijasdaniel factoresdeterminantesenelexitodeuntratamientoantitabaco
_version_	1718436361936044032

Factores determinantes en el éxito de un tratamiento antitabaco

Ejemplares similares